Nucleolin shields PTBP1 from autophagic degradation to sustain gemcitabine resistance in bladder cancer
- DOI
- 10.1016/j.drup.2026.101475
- Published
- 2027-01
- Container
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.drup.2026.101475,
title = {Nucleolin shields PTBP1 from autophagic degradation to sustain gemcitabine resistance in bladder cancer},
author = {Yunyi Liu and Yatao Wu and Juan Li and Ting Liu and Changyue Yuan and Yuxi Xu and Hailong Ou and Shu Zhou and Dan Qi and Huan Liao and Mingyang He and Bi Shi and Jason H. Huang and Erxi Wu and Xiaoxiao Hu},
year = {2027},
journal = {Drug Resistance Updates},
doi = {10.1016/j.drup.2026.101475},
url = {https://doi.org/10.1016/j.drup.2026.101475}
}RIS
TY - JOUR TI - Nucleolin shields PTBP1 from autophagic degradation to sustain gemcitabine resistance in bladder cancer AU - Yunyi Liu AU - Yatao Wu AU - Juan Li AU - Ting Liu AU - Changyue Yuan AU - Yuxi Xu AU - Hailong Ou AU - Shu Zhou AU - Dan Qi AU - Huan Liao AU - Mingyang He AU - Bi Shi AU - Jason H. Huang AU - Erxi Wu AU - Xiaoxiao Hu PY - 2027 JO - Drug Resistance Updates DO - 10.1016/j.drup.2026.101475 UR - https://doi.org/10.1016/j.drup.2026.101475 ER -
APA
Liu, Y., Wu, Y., Li, J., Liu, T., Yuan, C., Xu, Y., Ou, H., Zhou, S., Qi, D., Liao, H., He, M., Shi, B., Huang, J. H., Wu, E., & Hu, X. (2027). Nucleolin shields PTBP1 from autophagic degradation to sustain gemcitabine resistance in bladder cancer. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2026.101475
Source records
- crossref · retrieved 2026-09-26T19:36:26.905Z